Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Cash from Operations (2023 - 2025)

Camp4 Therapeutics' Cash from Operations history spans 3 years, with the latest figure at 6246000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 155.33% year-over-year to 6246000.0; the TTM value through Dec 2025 reached 29600000.0, up 35.03%, while the annual FY2025 figure was 29600000.0, 35.03% up from the prior year.
  • Cash from Operations for Q4 2025 was 6246000.0 at Camp4 Therapeutics, up from 11246000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 6246000.0 in Q4 2025 and bottomed at 14300000.0 in Q1 2025.
  • The 3-year median for Cash from Operations is 11246000.0 (2025), against an average of 9660555.56.
  • The largest YoY upside for Cash from Operations was 155.33% in 2025 against a maximum downside of 28.33% in 2025.
  • A 3-year view of Cash from Operations shows it stood at 11783000.0 in 2023, then grew by 4.2% to 11288000.0 in 2024, then surged by 155.33% to 6246000.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Cash from Operations are 6246000.0 (Q4 2025), 11246000.0 (Q3 2025), and 10300000.0 (Q2 2025).